Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help
Search by PDB author
1FI0
DownloadVisualize
BU of 1fi0 by Molmil
SOLUTION STRUCTURE OF HIV-1 VPR (13-33) PEPTIDE IN MICELLS
Descriptor: VPR PROTEIN
Authors:Engler, A, Stangler, T, Willbold, D.
Deposit date:2000-08-03
Release date:2001-02-28
Last modified:2022-02-23
Method:SOLUTION NMR
Cite:Solution structure of human immunodeficiency virus type 1 Vpr(13-33) peptide in micelles.
Eur.J.Biochem., 268, 2001
1KZV
DownloadVisualize
BU of 1kzv by Molmil
Structure of Human Immunodeficiency Virus Type 1 Vpr(34-51) Peptide in Chloroform Methanol
Descriptor: Vpr PROTEIN
Authors:Engler, A, Stangler, T, Willbold, D.
Deposit date:2002-02-08
Release date:2002-08-28
Last modified:2022-02-23
Method:SOLUTION NMR
Cite:Structure of human immunodeficiency virus type 1 Vpr(34-51) peptide in micelle containing aqueous solution.
Eur.J.Biochem., 269, 2002
1KZT
DownloadVisualize
BU of 1kzt by Molmil
Structure of Human Immunodeficiency Virus Type 1 Vpr(34-51) Peptide in DPC Micelle Containing Aqueous Solution
Descriptor: Vpr PROTEIN
Authors:Engler, A, Stangler, T, Willbold, D.
Deposit date:2002-02-08
Release date:2002-08-28
Last modified:2022-02-23
Method:SOLUTION NMR
Cite:Structure of human immunodeficiency virus type 1 Vpr(34-51) peptide in micelle containing aqueous solution.
Eur.J.Biochem., 269, 2002
1KZS
DownloadVisualize
BU of 1kzs by Molmil
Structure of Human Immunodeficiency Virus Type 1 Vpr(34-51) Peptide in Aqueous TFE Solution
Descriptor: Vpr PROTEIN
Authors:Engler, A, Stangler, T, Willbold, D.
Deposit date:2002-02-08
Release date:2002-08-28
Last modified:2022-02-23
Method:SOLUTION NMR
Cite:Structure of human immunodeficiency virus type 1 Vpr(34-51) peptide in micelle containing aqueous solution.
Eur.J.Biochem., 269, 2002
4X21
DownloadVisualize
BU of 4x21 by Molmil
The MAP kinase JNK3 as target for halogen bonding
Descriptor: CHLORIDE ION, Mitogen-activated protein kinase 10, N-ethyl-4-{[4-(1H-indol-3-yl)-5-iodopyrimidin-2-yl]amino}piperidine-1-carboxamide
Authors:Lange, A, Buettner, F.M, Guenther, M.B, Zimmermann, M.O, Hennig, S, Laufer, S.A, Stehle, T, Boeckler, F.
Deposit date:2014-11-25
Release date:2015-11-11
Last modified:2024-01-10
Method:X-RAY DIFFRACTION (1.95 Å)
Cite:Targeting the Gatekeeper MET146 of C-Jun N-Terminal Kinase 3 Induces a Bivalent Halogen/Chalcogen Bond.
J.Am.Chem.Soc., 137, 2015
5MTX
DownloadVisualize
BU of 5mtx by Molmil
Dibenzooxepinone inhibitor 12b in complex with p38 MAPK
Descriptor: 3-[(3-benzamido-4-fluoranyl-phenyl)amino]-~{N}-(2-morpholin-4-ylethyl)-11-oxidanylidene-6~{H}-benzo[c][1]benzoxepine-9-carboxamide, Mitogen-activated protein kinase 14, octyl beta-D-glucopyranoside
Authors:Buehrmann, M, Rauh, D.
Deposit date:2017-01-11
Release date:2017-09-06
Last modified:2020-07-29
Method:X-RAY DIFFRACTION (1.8 Å)
Cite:Design, Synthesis, and Biological Evaluation of Novel Type I(1)/2 p38 alpha MAP Kinase Inhibitors with Excellent Selectivity, High Potency, and Prolonged Target Residence Time by Interfering with the R-Spine.
J. Med. Chem., 60, 2017
5MTY
DownloadVisualize
BU of 5mty by Molmil
Dibenzosuberone inhibitor 8e in complex with p38 MAPK
Descriptor: Mitogen-activated protein kinase 14, octyl beta-D-glucopyranoside, ~{N}-[2,4-bis(fluoranyl)-5-[[14-(2-hydroxyethylcarbamoyl)-2-oxidanylidene-6-tricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3(8),4,6,11,13-hexaenyl]amino]phenyl]thiophene-2-carboxamide
Authors:Buehrmann, M, Rauh, D.
Deposit date:2017-01-11
Release date:2017-09-06
Last modified:2020-07-29
Method:X-RAY DIFFRACTION (2.31 Å)
Cite:Design, Synthesis, and Biological Evaluation of Novel Type I(1)/2 p38 alpha MAP Kinase Inhibitors with Excellent Selectivity, High Potency, and Prolonged Target Residence Time by Interfering with the R-Spine.
J. Med. Chem., 60, 2017

218500

PDB entries from 2024-04-17

PDB statisticsPDBj update infoContact PDBjnumon